- Home
- WIMI vs ECOR Comparison
WIMI vs ECOR Comparison
Compare WIMI & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- ECOR
- Stock Information
- Founded
- WIMI 2015
- ECOR 2005
- Country
- WIMI China
- ECOR United States
- Employees
- WIMI N/A
- ECOR N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WIMI Technology
- ECOR Health Care
- Exchange
- WIMI Nasdaq
- ECOR Nasdaq
- Market Cap
- WIMI 38.3M
- ECOR 37.1M
- IPO Year
- WIMI 2020
- ECOR 2018
- Fundamental
- Price
- WIMI $4.67
- ECOR $5.00
- Analyst Decision
- WIMI
- ECOR Strong Buy
- Analyst Count
- WIMI 0
- ECOR 2
- Target Price
- WIMI N/A
- ECOR $25.50
- AVG Volume (30 Days)
- WIMI 508.0K
- ECOR 45.7K
- Earning Date
- WIMI 01-01-0001
- ECOR 11-12-2025
- Dividend Yield
- WIMI N/A
- ECOR N/A
- EPS Growth
- WIMI N/A
- ECOR N/A
- EPS
- WIMI 1.43
- ECOR N/A
- Revenue
- WIMI $61,329,146.00
- ECOR $27,700,000.00
- Revenue This Year
- WIMI N/A
- ECOR $24.48
- Revenue Next Year
- WIMI N/A
- ECOR $44.35
- P/E Ratio
- WIMI $3.43
- ECOR N/A
- Revenue Growth
- WIMI N/A
- ECOR 30.16
- 52 Week Low
- WIMI $2.24
- ECOR $4.16
- 52 Week High
- WIMI $29.20
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- WIMI 56.96
- ECOR 46.15
- Support Level
- WIMI $4.61
- ECOR $4.86
- Resistance Level
- WIMI $5.04
- ECOR $5.28
- Average True Range (ATR)
- WIMI 0.47
- ECOR 0.27
- MACD
- WIMI -0.02
- ECOR 0.04
- Stochastic Oscillator
- WIMI 28.36
- ECOR 43.40
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.